Quality and Quantity: Evaluating Tumor Biology Alongside Novel Imaging on Diagnosis of Metastatic Hormone-sensitive Prostate Cancer

Eur Urol. 2022 May;81(5):437-439. doi: 10.1016/j.eururo.2021.12.038. Epub 2022 Jan 20.

Abstract

Tumor biology may play an important role as an effective predictive biomarker that is complementary to functional imaging for metastatic hormone-sensitive prostate cancer.

Publication types

  • Editorial

MeSH terms

  • Biology
  • Hormones
  • Humans
  • Male
  • Prostatic Neoplasms* / diagnostic imaging
  • Prostatic Neoplasms* / pathology

Substances

  • Hormones